OncoTherapy Science, Inc. (TYO:4564)
Japan flag Japan · Delayed Price · Currency is JPY
21.00
+1.00 (5.00%)
Oct 6, 2026, 3:30 PM JST

OncoTherapy Science Ratios and Metrics

Millions JPY. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
8,5738,0577,6064,3539,05413,292
Market Cap Growth
17.26%5.92%74.74%-51.92%-31.88%-38.71%
Enterprise Value
6,2475,8726,6613,7558,07711,071
Last Close Price
21.0021.0028.0020.0047.0069.00

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Forward PE
-25.4925.4925.4925.4925.49
PS Ratio
11.039.9710.147.147.9811.53
PB Ratio
3.653.7610.4512.3310.606.72
P/TBV Ratio
3.653.7610.4512.3310.606.72
PEG Ratio
-0.760.760.760.760.76

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
8.047.278.886.167.129.60

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Debt / Equity Ratio
-0.99-0.98-1.14-1.49-1.31-0.93
Net Debt / EBITDA Ratio
----1.020.90
Net Debt / FCF Ratio
-2.121.020.431.400.73
Asset Turnover
0.380.460.740.510.540.38
Inventory Turnover
12.4518.9916.6017.0410.9720.37
Quick Ratio
11.0912.972.851.992.043.70
Current Ratio
11.8113.663.382.282.344.31
Return on Equity (ROE)
-51.56%-63.44%-150.79%-213.42%-78.93%-101.74%
Return on Assets (ROA)
-23.87%-28.81%-49.27%-58.87%-32.98%-42.40%
Return on Capital Employed (ROCE)
-33.00%-37.00%-96.30%-220.50%-122.70%-98.70%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
-10.31%-11.29%-10.71%-29.59%-12.35%-19.34%
FCF Yield
-11.48%-12.21%-10.71%-28.23%-8.81%-19.03%
Buyback Yield / Dilution
-31.59%-25.69%-22.73%-10.45%-2.76%-6.31%